宏观周报-20250811

Market Overview - The U.S. stock market showed recovery last week, with the Nasdaq reaching a record closing high due to better-than-expected July non-farm payroll data and the Federal Reserve's decision to hold rates steady[5] - Initial jobless claims in the U.S. rose to 226,000, exceeding expectations, while continuing claims surged to the highest level since November 2021, indicating a weakening job market[8] - The Hang Seng and Shanghai Composite indices in China continued to decline, influenced by corporate earnings reports and U.S. tariffs on semiconductor imports[5] Economic Indicators - The U.S. services PMI for July was reported at 50.1, below the expected 51.5, raising concerns about domestic consumption resilience[24] - China's July exports reached $321.78 billion, up 7.2% year-on-year, surpassing the Bloomberg consensus of 5.6%[24] - China's July CPI was flat at 0% year-on-year, while PPI fell by 3.6%, indicating deflationary pressures[28] Monetary Policy and Interest Rates - The probability of a 25 basis point rate cut by the Federal Reserve in September has exceeded 90% due to economic concerns[5] - The Bank of England cut rates by 25 basis points, bringing the policy rate down to 4%[6] - The U.S. 10-year Treasury yield rose to 4.29%, while the Chinese 10-year yield fell to 1.69%[39] Investment Recommendations - Investors are advised to increase allocation to bond assets due to potential short-term risks in equity markets[5] - For low-risk investors, the Taikang Kaitai Overseas Short-Term Bond Fund, yielding over 6% in the past year, is recommended[67] - For high-risk investors, the Huaxia Hang Seng Biotechnology Index ETF, which has seen over 100% returns in the past year, is suggested due to its growth potential in the biotech sector[67]